Purchase of Methylation Custom Probes for sequencing
Closed Solicitation Posted
- Solicitation number
- 75N98026Q00783
- Agency
-
Office of Logisitics and Acquisition Operations
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- Q301 Reference Laboratory Testing
- Place of performance
- Durham, North Carolina 27709, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institutes of Health National Institute of Environmental Health Sciences seeks to purchase Methylation Custom Probes for DNA sequencing research on a non-competitive basis, with responses due July 21, 2026. The procurement is a commercial items acquisition under FAR 12.603, with TWIST BIOSCIENCE identified as the intended awardee.
Place of performance is Durham, NC (111 TW Alexander Drive, Research Triangle Park, NC 27709). The requirement supports epigenetics, mitochondrial biology, and metabolism research within the Mechanistic Toxicology Branch. The custom probes must enable flexible, customizable panel design for highly targeted interrogation of DNA methylation patterns, with particular emphasis on rat genome methylation analysis where commercially available solutions are limited or unavailable. The NAICS code is 541714, Research and Development in Biotechnology; the PSC code is Q301, Reference Laboratory Testing.
Offerors must be actively registered in SAM and provide UEI, TIN, and business size certification. Price quotations must include unit price, list price, shipping and handling costs, delivery timeframe, delivery terms, prompt payment discount terms, F.O.B. point, and product or catalog numbers. Respondents offering brand-name products must provide product documentation demonstrating compliance with required characteristics, quantity, estimated price, shipping and handling charges, and delivery timeframe. Evaluation factors include past performance, technical capability, special features, warranty, maintenance availability, and environmental considerations. This acquisition is not expected to exceed the simplified acquisition threshold and does not fall under the Defense Priorities and Allocations System.
Notice text
See attached
Files
| File | Type | Posted |
|---|---|---|
| 12-NON Competitive CSS 75N98026Q00783.docx | DOCX document | |
| 07-Statement of Need Twist.docx | DOCX document |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| NOI - DNA Sequencing of Bone Marrow Failure Syndro | Office of Logisitics and Acquisition Operations | No set-aside | |
| RNA sequencing and whole genome sequencing services | Office of Logisitics and Acquisition Operations | No set-aside | |
| NCSS - Bioruptor Pico Sonication Device | Office of Logisitics and Acquisition Operations | No set-aside | |
| Amplicon sequencing services | Office of Acquisitions and Grants | No set-aside | |
| Reagents and consumables for Roche immunostainers | Office of Logisitics and Acquisition Operations | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity